Uzin Utz SE (ETR:UZU)
Germany
· Delayed Price · Currency is EUR 71.00
-3.80 (-5.08%)
Apr 28, 2026, 5:37 PM CET
Uzin Utz SE Revenue
In the year 2025, Uzin Utz SE had annual revenue of 506.39M EUR with 6.19% growth. Uzin Utz SE had revenue of 254.64M in the half year ending December 31, 2025, with 8.10% growth.
Revenue
506.39M
Revenue Growth
+6.19%
P/S Ratio
0.71
Revenue / Employee
330.11K
Employees
1,534
Market Cap
358.15M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 506.39M | 29.51M | 6.19% |
| Dec 31, 2024 | 476.88M | -3.35M | -0.70% |
| Dec 31, 2023 | 480.23M | -7.72M | -1.58% |
| Dec 31, 2022 | 487.95M | 47.40M | 10.76% |
| Dec 31, 2021 | 440.55M | 56.35M | 14.67% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| H&R GmbH & Co. KGaA | 1.25B |
| Masterflex SE | 102.71M |
| Nabaltec AG | 202.27M |
| LANXESS Aktiengesellschaft | 5.67B |
| AlzChem Group AG | 575.05M |
| BRAIN Biotech AG | 49.01M |
| Verbio SE | 1.73B |
| H2APEX Group SCA | 11.06M |